Obstructive Jaundice

Obstructive (post-hepatic / surgical) jaundice results from mechanical blockage of bile flow anywhere between the hepatocyte canaliculus and the ampulla of Vater. It is a high-yield NEET PG surgery topic because it links biochemistry, imaging algorithms, Courvoisier's law, and a menu of drainage procedures into one integrated clinical story.

Definition and basic concept

Jaundice (icterus) is clinically detectable yellow discolouration of skin, sclera and mucosae when serum bilirubin exceeds 2 mg/dL (scleral icterus is the earliest sign, visible around 2–2.5 mg/dL). In obstructive jaundice the predominant rise is in conjugated (direct) bilirubin, because hepatocytes conjugate bilirubin normally but cannot excrete it past the obstruction, so it refluxes into blood.

The biochemical hallmark triad:

• Conjugated hyperbilirubinaemia (direct fraction >50% of total)
• Raised alkaline phosphatase (ALP) and gamma-glutamyl transferase (GGT) — the cholestatic enzymes
• Bilirubinuria with absent urobilinogen (dark urine, pale clay-coloured stools)

High-yield: In obstructive jaundice the urine is dark (conjugated bilirubin is water-soluble and renally excreted) and stools are pale/clay-coloured (no stercobilin reaching the gut). Urinary urobilinogen is absent in complete obstruction.

Classification of jaundice (the must-know table)

Feature	Pre-hepatic (haemolytic)	Hepatic (hepatocellular)	Post-hepatic (obstructive)
Bilirubin type	Unconjugated	Both	Conjugated
Urine colour	Normal	Dark	Dark
Urine bilirubin	Absent	Present	Present (++)
Urobilinogen	Increased	Variable	Absent/decreased
Stool	Normal/dark	Normal	Pale, clay
ALP	Normal	Mild rise	Markedly raised
ALT/AST	Normal	Markedly raised	Mild rise
Itching	No	Variable	Marked (bile salts)

High-yield: A disproportionate ALP rise with relatively preserved transaminases points to obstruction; a transaminase-dominant picture points to hepatocellular disease. To confirm ALP is of hepatic (not bony) origin, check GGT (raised) or heat-stable ALP fraction.

Surgical causes — classify by site and by lumen

A clean way to organise causes (NEET loves "luminal / mural / extramural"):

Level	Within lumen	In the wall	Outside (compression)
Intrahepatic	—	Sclerosing cholangitis, biliary atresia	Liver mets, cysts
Hilar	Stone	Cholangiocarcinoma (Klatskin), Mirizzi syndrome	Porta hepatis nodes
Distal CBD	Choledocholithiasis, parasites (Ascaris, Clonorchis)	CBD stricture, cholangiocarcinoma	Ca head of pancreas, chronic pancreatitis, pancreatic pseudocyst
Ampulla	Impacted stone	Ampullary/periampullary carcinoma	Duodenal tumour

The four classically tested causes (from the blurb):

1. Choledocholithiasis — commonest benign cause. Stones migrate from gallbladder into CBD. Presents with fluctuating jaundice, biliary colic, and raised ALP. The gallbladder is usually not palpable (chronically fibrosed) → Courvoisier negative.
2. Carcinoma head of pancreas — commonest malignant cause of surgical obstructive jaundice. Progressive, painless jaundice with palpable, non-tender gallbladder (Courvoisier positive). Often weight loss; may have Trousseau sign (migratory thrombophlebitis).
3. Cholangiocarcinoma — adenocarcinoma of bile duct epithelium. Klatskin tumour = perihilar type at confluence of right/left hepatic ducts (commonest). Risk factors: primary sclerosing cholangitis, choledochal cysts, Clonorchis sinensis, hepatolithiasis, ulcerative colitis.
4. Benign biliary strictures — most often post-cholecystectomy iatrogenic injury (commonest cause of benign stricture); also chronic pancreatitis, recurrent cholangitis.

High-yield: Commonest benign cause of obstructive jaundice = CBD stone. Commonest malignant cause = carcinoma head of pancreas. Commonest cause of benign biliary stricture = iatrogenic (bile duct injury during cholecystectomy).

Pathophysiology — why obstruction is dangerous

Bile stasis behind obstruction causes:

• Cholangitis: stasis + bacterial colonisation (E. coli, Klebsiella, Enterococcus). Ascending infection raises intraductal pressure → bacteraemia.
• Loss of bile salts in gut → fat malabsorption → fat-soluble vitamin (A, D, E, K) deficiency → vitamin K-dependent coagulopathy (prolonged PT/INR).
• Endotoxaemia: absence of intraluminal bile allows gut endotoxin absorption → predisposes to hepatorenal syndrome / acute kidney injury post-operatively.
• Hepatocyte injury & secondary biliary cirrhosis if chronic.

High-yield: Prolonged PT in obstructive jaundice that corrects with parenteral vitamin K indicates malabsorption (obstruction). Failure to correct indicates intrinsic hepatocellular failure. Always give parenteral vitamin K before biliary surgery/intervention.

Clinical features and named signs

Courvoisier's law: "In the presence of jaundice, a palpable, non-tender gallbladder is unlikely to be due to stones" — i.e. it suggests malignant distal obstruction (Ca head of pancreas, periampullary Ca). The logic: stones cause chronic cholecystitis and a fibrosed, non-distensible gallbladder, whereas malignant obstruction occurs in a previously normal, distensible gallbladder.

High-yield exceptions to Courvoisier's law (palpable GB with stones): double impaction (one stone in cystic duct causing mucocele + one in CBD), Mirizzi syndrome, oriental cholangiohepatitis, and a pancreatic stone obstructing CBD. Remember Courvoisier speaks of the gallbladder, not the cause.

Charcot's triad (ascending cholangitis): fever with rigors + jaundice + right upper quadrant pain.

Reynolds' pentad (suppurative cholangitis — emergency): Charcot's triad + hypotension (shock) + altered mental status/confusion.

High-yield: Reynolds' pentad = surgical/endoscopic emergency; needs urgent biliary decompression (ERCP) after resuscitation and antibiotics.

Other clues: pruritus (bile salt deposition), steatorrhoea, dark urine, weight loss (malignancy), Trousseau sign, palpable Virchow's node (left supraclavicular) in advanced pancreatic/gastric malignancy.

Investigations — the algorithm

Stepwise approach:

LFT + coagulation → Ultrasound abdomen (first investigation) → if dilated ducts/cause unclear → MRCP (best non-invasive imaging) → ERCP (if therapeutic intervention needed) or PTC (if proximal block / failed ERCP) → CT/EUS for staging if malignancy.

1. First-line: Ultrasound

• Investigation of choice to confirm obstruction (cheap, no radiation). Detects dilated bile ducts (CBD >6–7 mm in adults; add 1 mm per decade over 60, up to ~10 mm post-cholecystectomy), level of obstruction, gallstones, liver mass.
• A dilated intra- and extra-hepatic system localises obstruction to distal CBD; dilated intrahepatic ducts with normal CBD = hilar block (Klatskin).

2. MRCP (Magnetic Resonance Cholangiopancreatography)

• Best non-invasive, purely diagnostic investigation for biliary tree anatomy. Excellent for stones, strictures, ductal anatomy before planning intervention. No contrast, no radiation, no risk of pancreatitis.

3. ERCP (Endoscopic Retrograde Cholangiopancreatography)

• Both diagnostic and therapeutic — the key advantage. Allows sphincterotomy, stone extraction, stenting, brush cytology, biopsy.
• Best for distal obstruction (stones, periampullary tumours).
• Main complication: post-ERCP pancreatitis (commonest); also bleeding, perforation, cholangitis.

4. PTC (Percutaneous Transhepatic Cholangiography)

• Needle puncture of intrahepatic duct under imaging. Preferred for proximal/hilar obstruction (Klatskin) or when ERCP fails or anatomy is altered (e.g. previous gastric bypass).
• Allows external/internal biliary drainage (PTBD).

5. EUS and CT

• EUS (endoscopic ultrasound): best for small periampullary/pancreatic head lesions, CBD microlithiasis, and FNA for tissue.
• Triple-phase CT / CT angiography: staging, vascular involvement, resectability of pancreatic/biliary malignancy.

Modality	Diagnostic	Therapeutic	Best used for	Key risk
Ultrasound	Yes (screen)	No	Confirm dilatation, first test	None
MRCP	Yes (best non-invasive)	No	Anatomy, stones, strictures	None
ERCP	Yes	Yes	Distal block, stone removal, stent	Pancreatitis
PTC/PTBD	Yes	Yes	Proximal/hilar block, failed ERCP	Bleeding, bile leak
EUS	Yes (+FNA)	Limited	Small periampullary/pancreatic mass	Low

High-yield: USG = first test to confirm obstruction. MRCP = best diagnostic non-invasive map. ERCP = best therapeutic for distal stones. PTC = preferred for proximal/hilar lesions. CA 19-9 = tumour marker for pancreatic and cholangiocarcinoma (also raised in cholangitis — interpret after decompression).

Management — principles and definitive options

General/preoperative optimisation

1. Correct coagulopathy — parenteral vitamin K; FFP if urgent and INR high.
2. Hydration to prevent hepatorenal syndrome; some give mannitol preoperatively to maintain diuresis in deeply jaundiced patients.
3. Treat cholangitis — IV broad-spectrum antibiotics (cover Gram-negatives/anaerobes) and urgent biliary drainage (ERCP) in cholangitis/sepsis.
4. Nutritional support; treat pruritus (cholestyramine, rifampicin).
5. Preoperative biliary drainage is not routine — reserved for cholangitis, very high bilirubin, planned neoadjuvant therapy, or before major hepatectomy; routine stenting before pancreaticoduodenectomy increases infective complications.

Cause-specific definitive management

Choledocholithiasis → ERCP + sphincterotomy + stone extraction (balloon/basket) is the mainstay; followed by laparoscopic cholecystectomy for the source. Large/impacted stones may need mechanical lithotripsy or laparoscopic CBD exploration. Open CBD exploration with T-tube drainage is now reserved for failed endoscopic approaches.

Carcinoma head of pancreas / periampullary carcinoma → if resectable, Whipple's pancreaticoduodenectomy (removal of pancreatic head, duodenum, distal stomach—classic, antrum-preserving in pylorus-preserving variant, gallbladder, distal CBD; with pancreatico-, hepatico-/choledocho-, and gastro-jejunostomy reconstruction). If unresectable → palliative biliary stenting (ERCP/metal SEMS) ± gastrojejunostomy for duodenal obstruction; surgical triple bypass (choledochojejunostomy + gastrojejunostomy + ± enteroenterostomy) in selected fit patients.

Cholangiocarcinoma:

• Klatskin (perihilar) — resection per Bismuth–Corlette type, often with hepatectomy + caudate lobe resection + Roux-en-Y hepaticojejunostomy.
• Distal CBD — Whipple's procedure.
• Intrahepatic — hepatic resection.
• Unresectable → palliative stenting (PTBD/SEMS).

Benign biliary stricture → Roux-en-Y hepaticojejunostomy is the gold-standard definitive repair; short strictures may respond to endoscopic balloon dilatation + stenting.

High-yield: Bismuth–Corlette classification stages hilar cholangiocarcinoma: Type I below confluence; Type II reaches confluence; Type IIIa extends into right hepatic duct, IIIb into left; Type IV involves both or is multifocal (often unresectable). Type IV → consider transplant in selected centres.

High-yield: Roux-en-Y hepaticojejunostomy is the answer for definitive repair of benign post-cholecystectomy strictures and for biliary-enteric reconstruction.

Complications

• Acute cholangitis / sepsis (Reynolds' pentad → multi-organ failure)
• Coagulopathy and bleeding
• Hepatorenal syndrome / postoperative acute kidney injury — classic in deeply jaundiced surgical patients
• Secondary biliary cirrhosis and portal hypertension (chronic obstruction)
• Cholangitic liver abscesses
• Malabsorption, weight loss, fat-soluble vitamin deficiency
• Post-ERCP: pancreatitis, perforation, bleeding
• Gallstone ileus / Mirizzi syndrome as both cause and complication of stone disease

Key differentials (and how to separate them)

1. Medical (hepatocellular) jaundice — hepatitis: ALT/AST markedly up, ALP mildly up, ducts not dilated on USG, viral serology positive.
2. Drug-induced cholestasis — flucloxacillin, oral contraceptives, anabolic steroids: cholestatic LFTs but non-dilated ducts.
3. Primary biliary cholangitis (PBC) — middle-aged woman, pruritus, AMA positive, raised IgM.
4. Primary sclerosing cholangitis (PSC) — associated with ulcerative colitis, "beaded" ducts on MRCP/ERCP, p-ANCA, risk of cholangiocarcinoma.
5. Choledochal cyst — congenital cystic dilatation (Todani classification; Type I commonest), childhood jaundice + mass + pain, risk of malignancy → excision + hepaticojejunostomy.
6. Mirizzi syndrome — stone in cystic duct/Hartmann's pouch compressing CBD → obstructive jaundice with stones (Courvoisier exception).

High-yield: Dilated ducts on ultrasound = surgical (obstructive) jaundice; non-dilated ducts = medical jaundice. This single sonographic finding directs the entire pathway.

Mnemonics

• Causes of obstructive jaundice — "I CAMPS": Iatrogenic stricture, Choledocholithiasis, Ampullary/cholangio carcinoma, Mirizzi, Pancreatic head Ca, Sclerosing cholangitis/parasites.
• Charcot's triad — "Fever, Jaundice, Pain" (FJP); add Shock + Sensorium for Reynolds' pentad.
• Fat-soluble vitamins lost — "ADEK".

Recently asked / exam angle

• Courvoisier's law and its exceptions (double impaction, Mirizzi, pancreatic calculus) — perennial favourite; expect a clinical vignette with painless progressive jaundice + palpable gallbladder → answer Ca head of pancreas.
• Best investigation stems: "non-invasive imaging of biliary tree" → MRCP; "diagnostic + therapeutic" → ERCP; "first investigation" → USG; "proximal/hilar block, failed ERCP" → PTC.
• Charcot's triad / Reynolds' pentad identification and the correct emergency step (urgent ERCP decompression).
• Bismuth–Corlette typing of Klatskin tumour and which type is usually unresectable (Type IV).
• Commonest cause stems: benign → CBD stone; malignant → Ca head of pancreas; benign stricture → iatrogenic.
• Tumour marker of pancreatic/cholangiocarcinoma → CA 19-9 (caution: falsely raised in cholangitis and in Lewis-antigen-negative patients it is undetectable).
• Pre-op coagulopathy correction with vitamin K; prevention of hepatorenal syndrome with hydration/mannitol.
• Definitive repair of post-cholecystectomy stricture → Roux-en-Y hepaticojejunostomy.
• Whipple's procedure components and reconstruction order — frequently asked as image/diagram-based question.
• Risk factors for cholangiocarcinoma — PSC, choledochal cyst, Clonorchis, hepatolithiasis, UC.

Rapid revision

1. Obstructive jaundice = conjugated hyperbilirubinaemia + high ALP/GGT + dark urine + pale stools + absent urobilinogen.
2. Scleral icterus appears first (~2–2.5 mg/dL bilirubin).
3. USG is the first test; dilated ducts = surgical, non-dilated = medical.
4. MRCP = best non-invasive map; ERCP = best diagnostic + therapeutic for distal stones; PTC = proximal/hilar or failed ERCP.
5. Courvoisier's law: palpable non-tender gallbladder + jaundice → think malignancy (Ca head of pancreas), unlikely stones.
6. Courvoisier exceptions: double impaction, Mirizzi, pancreatic calculus, oriental cholangiohepatitis.
7. Charcot's triad = fever+jaundice+RUQ pain; Reynolds' pentad adds shock + confusion = emergency → urgent decompression.
8. Commonest benign cause = CBD stone; commonest malignant cause = Ca head of pancreas; commonest benign stricture cause = iatrogenic.
9. Correct vitamin K-dependent coagulopathy before any biliary intervention; PT corrects with parenteral vitamin K in obstruction.
10. Klatskin tumour = perihilar cholangiocarcinoma; stage by Bismuth–Corlette (Type IV usually unresectable).
11. Whipple's pancreaticoduodenectomy for resectable Ca head of pancreas/distal cholangiocarcinoma; Roux-en-Y hepaticojejunostomy for benign strictures and biliary-enteric bypass.
12. CA 19-9 = marker for pancreatic and cholangiocarcinoma; post-ERCP pancreatitis is the commonest ERCP complication.